Arca
Skip to content

PDGFRB: Platelet-derived growth factor receptor beta

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Tyrosine-protein kinase that acts as a cell-surface receptor for homodimeric PDGFB and PDGFD and for heterodimers formed by PDGFA and PDGFB, and plays an essential role in the regulation of embryonic development, cell proliferation, survival, differentiation, chemotaxis and migration.

  • Drugs that act on it: 17
  • With a US drug page: 4
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it. All act as: Platelet-derived growth factor receptor beta inhibitor.
ImatinibApproved—Inhibitor—
SorafenibApproved—Inhibitor—
SunitinibApproved—InhibitorBoxed warning
TivozanibApproved—Inhibitor—
Catequentinib——Inhibitor—
CDP-860——Inhibitor—
CEP-2563——Inhibitor—
CM-082——Inhibitor—
Dasatinib anhydrous——Inhibitor—
JI-101——Inhibitor—
PD-0166285——Inhibitor—
Puquitinib——Inhibitor—
RG-1530——Inhibitor—
Rinucumab——Inhibitor—
Tandutinib——Inhibitor—
Telatinib——Inhibitor—
TG100-801——Inhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Bilateral striopallidodentate calcinosis
0.79
Myofibromatosis, infantile, 1
0.76
Infantile myofibromatosis
0.75
Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome
0.74
Acroosteolysis-keloid-like lesions-premature aging syndrome
0.74
Neoplasm
0.65
Non-small cell lung carcinoma
0.60

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
PDGFRB

Drugs and mechanisms are from ChEMBL CHEMBL1913 (CC BY-SA 3.0). Gene name, function (UniProt P09619, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.